INTRACELLULAR CALCIUM STORE & SMOOTH MUSCLE CELL CA INDEPENDNT PHOSPHOLIPOASE A2
INTRACELLULAR CALCIUM STORE & SMOOTH MUSCLE CELL CA INDEPENDNT PHOSPHOLIPOASE A2
批准号:
6118609
负责人:
Matthew J Wolf
金额:
$0.08万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
1998
资助国家:
美国
项目状态:
已结题
起止时间:
1998-08-01 至 1999-07-31
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Herein we present multiple lines of evidence which demonstrate
that depletion of internal calcium stores is both necessary and
sufficient for the activation of calcium-independent phospholipase A2
during arginine vasopressin (AVP)-mediated mobilization of arachidonic
acid in A-10 smooth muscle cells. First, AVP-induced [3H]arachidonic
acid release was independent of increases in cytosolic calcium yet was
decreased by pharmacological inhibition of the release of calcium ion
from internal stores. Second, thapsigargin induced the dramatic
release of [2H]arachidonic acid from A-10 cells at a similar rate as
the AVP-induced release of arachidonic acid, and the release of
arachidonic acid by either AVP or thapsigargin was entirely inhibited
by (E)-6-(bromomethylene)-3-(1-naphthalenyl)-2H-tetrahydropyran-2-one
(BEL). A23187 and thapsigargin also induce arachidonate release from
pancreatic islet beta cells, as demonstrated by isotope dilution mass
spectrometry, by a BEL-sensitive mechanism. Collectively, these
results identify a novel paradigm which links alterations in calcium
homeostasis to the calmodulin-mediated regulation of
calcium-independent phospholipase A2 through the depletion of internal
calcium stores.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
A CRISPR-based modular transgenic system to advance in vivo investigations of angiogenesis and fibrosis
-
批准号:10408193
-
项目类别:
-
资助金额:$24.23万
-
财政年份:2022
-
负责人:Matthew J Wolf
-
依托单位:
DYRK1a as a therapeutic target to treat myocardial infarction
-
批准号:10458688
-
项目类别:
-
资助金额:$40.38万
-
财政年份:2021
-
负责人:Matthew J Wolf
-
依托单位:
DYRK1a as a therapeutic target to treat myocardial infarction
-
批准号:10274952
-
项目类别:
-
资助金额:$40.38万
-
财政年份:2021
-
负责人:Matthew J Wolf
-
依托单位:
DYRK1a as a therapeutic target to treat myocardial infarction
-
批准号:10670197
-
项目类别:
-
资助金额:$40.38万
-
财政年份:2021
-
负责人:Matthew J Wolf
-
依托单位:
Novel pathways modulating Raf-mediated cardiac hypertrophy
-
批准号:9001357
-
项目类别:
-
资助金额:$39.5万
-
财政年份:2015
-
负责人:Matthew J Wolf
-
依托单位:
Novel pathways modulating Raf-mediated cardiac hypertrophy
-
批准号:9097132
-
项目类别:
-
资助金额:$23.89万
-
财政年份:2015
-
负责人:Matthew J Wolf
-
依托单位:
Novel pathways modulating Raf-mediated cardiac hypertrophy
-
批准号:8417126
-
项目类别:
-
资助金额:$39.25万
-
财政年份:2013
-
负责人:Matthew J Wolf
-
依托单位:
Novel pathways modulating Raf-mediated cardiac hypertrophy
-
批准号:8794338
-
项目类别:
-
资助金额:$14.77万
-
财政年份:2013
-
负责人:Matthew J Wolf
-
依托单位:
Novel pathways modulating Raf-mediated cardiac hypertrophy
-
批准号:8611966
-
项目类别:
-
资助金额:$38.47万
-
财政年份:2013
-
负责人:Matthew J Wolf
-
依托单位:
Genetic modifiers of dilated cardiomyopathy in adult Drosophila
-
批准号:7888344
-
项目类别:
-
资助金额:$12.62万
-
财政年份:2007
-
负责人:Matthew J Wolf
-
依托单位:
Genetic modifiers of dilated cardiomyopathy in adult Drosophila
-
批准号:7670276
-
项目类别:
-
资助金额:$12.62万
-
财政年份:2007
-
负责人:Matthew J Wolf
-
依托单位:
Genetic modifiers of dilated cardiomyopathy in adult Drosophila
-
批准号:7477725
-
项目类别:
-
资助金额:$12.62万
-
财政年份:2007
-
负责人:Matthew J Wolf
-
依托单位:
Genetic modifiers of dilated cardiomyopathy in adult Drosophila
-
批准号:7127746
-
项目类别:
-
资助金额:$12.62万
-
财政年份:2007
-
负责人:Matthew J Wolf
-
依托单位:
Genetic modifiers of dilated cardiomyopathy in adult Drosophila
-
批准号:8111930
-
项目类别:
-
资助金额:$12.62万
-
财政年份:2007
-
负责人:Matthew J Wolf
-
依托单位:
DEPLETION OF INTRACELLULAR CALCIUM ACTIVATE SMOOTH MUSCLE CELL PHOSPHOLIPOASE A2
-
批准号:6249778
-
项目类别:
-
资助金额:$0.42万
-
财政年份:1997
-
负责人:Matthew J Wolf
-
依托单位:
海外基金